Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification
International Journal of Molecular Sciences · 20.03.2026 · 27 (6) · 2847
DOI: 10.3390/ijms27062847 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.03.2026. Verfasst von Akshaya Poonepalle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Human Papillomavirus Viruses, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is biologically and clinically dichotomous according to HPV status, a distinction that fundamentally dictates the design, implementation, and interpretation of liquid biopsy strategies. Conventional anatomical imaging lacks sufficient sensitivity for minimal residual disease (MRD) detection, contributing significantly to treatment failure and suboptimal clinical outcomes. This review provides a critical, evidence-based synthesis of the three principal circulating analytes, circulating tumor DNA (ctDNA), exosomes, and circulating tumor cells (CTCs), and their evolving roles in real-time, non-invasive molecular monitoring. Critically, the clinical readiness of these analytes differs substantially: while ctDNA, particularly HPV-related ctDNA, is approaching clinical validation for MRD detection and recurrence surveillance in HPV-positive HNSCC, exosomes and CTCs remain investigational tools hindered by ongoing technical challenges including lack of standardized assays, limited reproducibility across platforms, and insufficient prospective validation. We review how the presence of a clonal, virally derived DNA target in HPV-positive HNSCC contrasts with the heterogeneous somatic mutational landscape of HPV-negative tumors, necessitating divergent analytical platforms and yielding distinct clinical utility profiles for MRD detection and recurrence surveillance. We further outline a pragmatic translational pathway focused on assay standardization, particularly for exosomes and CTCs where this foundational work is most urgently needed, integration of complementary multimodal liquid biopsy approaches, and rigorously designed prospective interventional clinical trials to establish clinical utility. Collectively, these efforts aim to transition HNSCC management from reactive, anatomy-based surveillance to proactive, molecularly guided precision oncology, with the potential to improve therapeutic decision-making and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
- School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Nabil F Saba, Yang Liu, Yong Teng
Zitieren
APA
Poonepalle, A., Yang, J., Saba, N. F., Liu, Y., & Teng, Y. (2026). Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification. International Journal of Molecular Sciences, 27(6), 2847. https://doi.org/10.3390/ijms27062847
Vancouver
Poonepalle A, Yang J, Saba NF, Liu Y, Teng Y. Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification. International Journal of Molecular Sciences. 2026;27(6):2847. doi:10.3390/ijms27062847
BibTeX
@article{Poonepalle2026,
author = {Poonepalle, Akshaya and Yang, Jianqiang and Saba, Nabil F and Liu, Yang and Teng, Yong},
title = {Liquid Biopsies in HNSCC: Current Landscape and Emerging Opportunities in the Era of HPV Stratification},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2847},
doi = {10.3390/ijms27062847}
}
EUVIMED